Skip to main content


Human iPSC-derived Cortical Neurons for Research and Development. The project aims to make highly functional human cortical neurons from stem cells. Right now these cellular models, in combination with laboratory tests, provide a unique and novel platform bridging traditional laboratory tests and clinical testing in patients. Showing close resemblance to...
Read More

Arc Protonthérapie

Project co-led by MecaTech and BioWin. The project aims to develop an innovative variation of the classical technique of delivery of proton therapy by intensity modulation. This new technique is called "Arc Protontherapy". This new technique allows to deliver the dose continuously during rotation of the gantry. For the patient, Arc...
Read More


Development of a powerful therapy to fight antimicrobial resistance. The aim of the Inteliphages project is to develop dried and encapsulated phages in order to treat bacterial infections that are either resistant to antibiotics or for which antibiotics are not indicated for other reasons. The development of dried and encapsulated...
Read More


Asthma and COPD (Chronic Obstructive Pulmonary Disease) are amongst the most common causes of mortality and morbidity worldwide, representing together the third largest medical market. Their prevalence is increasing due to the global industrial pollution. Inhaled therapies, the preferred treatment options, are made of a drug combined with a medical...
Read More


When surgical removal is not possible, oncologists have few treatment options to offer their cancer patients. Trasis, Xpress Biologics, CMMI (ULB) and UMONS are embarking on the FAR (Fragments of Antibodies for Radioimmunotherapy) research project to promote the use of antibody fragments as carriers of radioactive isotopes. By using both the ability of antibody fragments to target tumours and...
Read More


The BoneRec project aims to develop a new tissue-engineered product indicated for bone reconstruction. This ideal bone graft substitute will be biomechanically stable, resorbable and will have osteoconductive, osteogenic and osteoinductive properties. The biomechanical property will be provided by Cerhum's ceramic graft (coordinating company of the project) and the osteoconductive,...
Read More


M2-Target aims to develop a non-invasive imaging method for the detection and quantification of M2 macrophages. This method is based on a new radiotracer (called 68Ga-ABSCINT-206) initially developed at the Vrije Universiteit Brussel (VUB). It is composed of a single-domain antibody fragment (also called "nanobodies") that recognizes a receptor (CD206)...
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!